Lobbying activity

2A

BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate

Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Medical/Disease Research/Clinical Labs

View → 2A

BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate

Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Medical/Disease Research/Clinical Labs

View → Q2

CORNELL UNIVERSITY for CORNELL UNIVERSITY

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate

Budget/Appropriations, Taxation/Internal Revenue Code, Agriculture, Medical/Disease Research/Clinical Labs

View → Q2

STEPTOE LLP for VELICO MEDICAL INC.

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $10,000.00 income

Disaster Planning/Emergencies, Medical/Disease Research/Clinical Labs

View → Q2

THE TEXAS A&M UNIVERSITY SYSTEM for THE TEXAS A&M UNIVERSITY SYSTEM

2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate

Education, Homeland Security, Science/Technology, Transportation

View → Q2

AGIOS PHARMACEUTICALS for AGIOS PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate

Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid

View → Q2

BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate

Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Medical/Disease Research/Clinical Labs

View → Q2

ALSTON & BIRD LLP for OREGON HEALTH & SCIENCE UNIVERSITY

2nd Quarter (Apr 1 - June 30) 2026 · Oregon · House · Senate · $40,000.00 income

Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Health Issues

View → Q2

MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) for MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE)

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate

Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Budget/Appropriations, Health Issues

View → Q2

INFLECTION POINT (FKA ARISTOTLE INTERNATIONAL, INC.) for AMERICAN UROLOGICAL ASSOCIATION

2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $40,000.00 income

Medical/Disease Research/Clinical Labs

View → Q2

BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid

View → Q2

UNIVERSITY OF GEORGIA for UNIVERSITY OF GEORGIA

2nd Quarter (Apr 1 - June 30) 2026 · Georgia · House · Senate

Defense, Marine/Maritime/Boating/Fisheries, Small Business, Medical/Disease Research/Clinical Labs

View → Q1

ALPINE GROUP PARTNERS, LLC. for PHRMA

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income

Health Issues, Government Issues, Medical/Disease Research/Clinical Labs, Pharmacy

View → Q1

ALPINE GROUP PARTNERS, LLC. for ULTRAGENYX PHARMACEUTICAL INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $40,000.00 income

Health Issues, Government Issues, Medical/Disease Research/Clinical Labs

View → Q2

ALPINE GROUP PARTNERS, LLC. for ULTRAGENYX PHARMACEUTICAL INC.

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $60,000.00 income

Health Issues, Government Issues, Medical/Disease Research/Clinical Labs

View → Q2

UNIVERSITY OF VIRGINIA for UNIVERSITY OF VIRGINIA

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate

Medical/Disease Research/Clinical Labs, Budget/Appropriations, Defense, Immigration

View → Q2

MILLER STRATEGIES, LLC for ULTRAGENYX PHARMACEUTICAL INC.

2nd Quarter (Apr 1 - June 30) 2026 · California · $140,000.00 income

Medical/Disease Research/Clinical Labs

View → Q2

MICHAEL BEST STRATEGIES LLC for LONG ISLAND UNIVERSITY

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · $40,000.00 income

Education, Defense, Medical/Disease Research/Clinical Labs

View → Q2

DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate

Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs

View → Q2

WILLIAMS AND JENSEN, PLLC for SANOFI, U.S.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code

View → Q2

NATIONAL MULTIPLE SCLEROSIS SOCIETY for NATIONAL MULTIPLE SCLEROSIS SOCIETY

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs

View → Q2

WILLIAMS AND JENSEN, PLLC for SYNEOS HEALTH, INC.

2nd Quarter (Apr 1 - June 30) 2026 · North Carolina · House · Senate · $30,000.00 income

Medical/Disease Research/Clinical Labs, Pharmacy, Taxation/Internal Revenue Code

View → Q2

BGR GOVERNMENT AFFAIRS for PREMIA SPINE

2nd Quarter (Apr 1 - June 30) 2026 · Connecticut · House · Senate · $20,000.00 income

Medical/Disease Research/Clinical Labs

View → Q2

UNIVERSITY OF ROCHESTER for UNIVERSITY OF ROCHESTER

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate

Arts/Entertainment, Budget/Appropriations, Education, Energy/Nuclear

View → Q2

NORTH CAROLINA STATE UNIVERSITY for NORTH CAROLINA STATE UNIVERSITY

2nd Quarter (Apr 1 - June 30) 2026 · North Carolina · House · Senate

Budget/Appropriations, Education, Defense, Copyright/Patent/Trademark

View →